-
N2703 Workflow for Adipose-Neural Assays
2026-09-08
Learn how to position 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled chemical perturbation in adipose-neural and cardiomyocyte experiments. The workflow emphasizes dose-finding, solvent control, orthogonal readouts, and careful separation between reference-study evidence and hypothesis-generating applications.
-
Sumatriptan Beyond Migraine: Anti-Inflammatory Evidence
2026-09-08
A systematic review by Ala and colleagues synthesizes evidence that sumatriptan may regulate inflammatory signaling beyond its established use in migraine. The review connects 5-HT1B/1D receptor activity with cytokine, nitric oxide, CGRP, caspase, and NF-κB pathways, while also highlighting the limitations of translating heterogeneous experimental findings into new clinical indications.
-
Polybrene Workflows for Efficient Gene Delivery
2026-09-07
Polybrene (Hexadimethrine Bromide) helps standardize viral attachment and uptake while also supporting difficult lipid-mediated DNA transfection workflows. This guide turns the reagent into a controlled optimization strategy and connects delivery controls with the mitochondrial OGDH biology highlighted in recent research.
-
Natural Compounds Against SARS-CoV-2: Docking Study
2026-09-07
This 2022 Journal of Molecular Modeling study used virtual screening, molecular docking, and molecular dynamics to evaluate natural compounds against the SARS-CoV-2 receptor-binding domain and 3CLpro. Its main contribution is a dual-target computational framework that identifies several vitamin-related molecules as candidates for blocking viral entry and replication, while also highlighting the need for biochemical and cellular validation.
-
LG 101506 in RXR Signaling Research
2026-09-05
Learn how to use LG 101506 as a controlled chemical probe for RXR biology, metabolism regulation, and nuclear receptor assays. This workflow pairs dose-response discipline with orthogonal readouts and a cautious, hypothesis-generating extension to PD-L1 research in triple-negative breast cancer.
-
Proteinase K Workflows for DNA Integrity
2026-09-04
Proteinase K combines broad protein digestion with compatibility across SDS, EDTA, and flexible temperature conditions, making it a practical choice for genomic DNA isolation and enzyme contaminant removal. This guide translates its biochemical strengths—and its distinct role as a control protease in SARS-CoV-2 3CLpro research—into executable workflows and troubleshooting decisions.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-09-04
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central innovation is a dual-genome mechanism: dasatinib preferentially suppresses nuclear-encoded OXPHOS genes, while LRPPRC inhibition disrupts mitochondrial genome-encoded OXPHOS expression, providing a rationale for combination therapy in LRPPRC-high tumors.
-
3X (DYKDDDDK) Peptide for EMC Workflows
2026-09-03
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-based capture, elution, and detection while preserving options for membrane-complex studies. This practical guide connects FLAG workflows with EMC structural biology, including cryo-EM sample preparation, metal-sensitive assays, and troubleshooting.
-
From P2RX1 Biology to Better Apoptosis Decisions
2026-09-03
A translational framework for connecting P2RX1-driven mitochondrial stress in Ph+ ALL with rapid, decision-ready apoptosis and necrosis measurements using the Annexin V-Cy5/DAPI Apoptosis Kit.
-
Pertussis toxin: Immune Assay Workflow Guide
2026-09-02
Learn how to use Pertussis toxin as a controlled cAMP-pathway perturbation in dendritic-cell, T-cell, and vascular assays. This workflow guide emphasizes dose-finding, orthogonal readouts, storage discipline, and careful interpretation alongside the Dhx9–TH17 research framework.
-
25-Hydroxycholesterol Reprograms TAM Metabolism
2026-09-02
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that links lysosomal lipid sensing to AMPKα–STAT6 signaling and ARG1 production in tumor-associated macrophages. Their findings show that targeting this axis can increase T-cell activity and improve anti-PD-1 responses, while also providing a framework for studying metabolic interventions in the tumor microenvironment.
-
LAG-3–TCR Proximity in T Cell Suppression
2026-09-01
A 2025 Cell study shows that LAG-3 inhibition depends less on MHC class II binding alone than on LAG-3 being positioned near the T cell receptor. The work identifies disruption of CD3ε–Lck association as a mechanism and develops an Fc-attenuated LAG-3/TCR bispecific antibody that suppresses pathogenic CD4+ and CD8+ T cells in autoimmune models.
-
Protease Inhibitor Cocktail for Multi-Omics
2026-09-01
A Protease Inhibitor Cocktail can preserve fragile signaling proteins while supporting better interpretation of cancer stem cell multi-omics workflows. This guide explains how an EDTA-free formulation helps align protein extraction with metabolomics, phosphorylation analysis, and assay-specific controls.
-
Verapamil in Hypoxia-Driven Inflammation
2026-08-31
Verapamil ((±)-Verapamil) is a calcium channel blocker and first-generation P-glycoprotein inhibitor used in cardiovascular and drug-transport research. In a urothelial hypoxia model, verapamil attenuated prolonged-hypoxia-associated caspase-1 elevation, supporting its use as a pharmacological perturbation of ROS-linked TXNIP/NLRP3 signaling rather than as proof of selective pathway inhibition.
-
GSK2606414: A Causal Test of PERK in NAFLD
2026-08-31
Explore how GSK2606414, a selective PERK inhibitor, can convert PERK activation from a correlation into a testable mechanism in TMAO-associated fatty liver disease. This guide integrates PERK biology, zebrafish and hepatic-cell evidence, assay design, controls, and translational limitations.